Xenetic Biosciences (XBIO)
(Delayed Data from NSDQ)
$3.90 USD
+0.06 (1.62%)
Updated May 24, 2024 03:06 PM ET
2-Buy of 5 2
C Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.83 |
EPS Last Quarter | -0.78 |
Last EPS Surprise | 1.27% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.96 |
Next Year | -0.73 |
EPS (TTM) | -2.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.54M | 0.57M | 2.20M | 1.80M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.54M | 0.57M | 2.20M | 1.80M |
Low Estimate | 0.54M | 0.57M | 2.20M | 1.80M |
Year ago Sales | 0.65M | 0.61M | 2.54M | 2.20M |
Year over Year Growth Est. | -16.92% | -6.56% | -13.39% | -18.18% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.83 | -0.15 | -0.96 | -0.73 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | -0.96 | -0.73 |
High Estimate | -0.83 | -0.15 | -0.96 | -0.73 |
Low Estimate | -0.83 | -0.15 | -0.96 | -0.73 |
Year ago EPS | -0.69 | -0.69 | -2.71 | -0.96 |
Year over Year Growth Est. | -20.29% | 78.26% | 64.58% | 23.96% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.83 | -0.15 | -0.96 | -0.73 |
7 Days Ago | -0.83 | -0.15 | -0.96 | -0.73 |
30 Days Ago | -0.83 | -0.15 | -3.43 | -0.82 |
60 Days Ago | -0.83 | -0.15 | -3.43 | -0.82 |
90 Days Ago | NA | NA | -0.64 | -0.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.83 | -0.15 | -0.96 | -0.73 |
Zacks Consensus Estimate | -0.83 | -0.15 | -0.96 | -0.73 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.78 | -0.77 | -0.69 | -0.69 | NA |
Estimate | -0.79 | -0.87 | -1.12 | -1.13 | NA |
Difference | 0.01 | 0.10 | 0.43 | 0.44 | 0.25 |
Surprise | 1.27% | 11.49% | 38.39% | 38.94% | 22.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more